Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell-leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination.
Dendritic cells (DC) have been successfully used in clinical pilot studies to induce tumor-specific immunity as well as clinical response in selected patients. However, DC-based immunotherapy remains a challenge and several parameters need to be examined in order to optimize the induction of anti-tu...
Main Authors: | Galea-Lauri, J, Darling, D, Mufti, G, Harrison, P, Farzaneh, F |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado: |
2002
|
Títulos similares
-
Dendritic cell/tumour fusions are more efficient at eliciting MHC class I-restricted Ag-specific CTL responses when compared to antigen-pulsed dendritic cells
por: Galea-Lauri, J, et al.
Publicado: (2001) -
Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
por: Galea-Lauri, J, et al.
Publicado: (2004) -
A comparison of CTL induction by different methods of antigen loading of monocyte-derived dendritic cells
por: Galea-Lauri, J, et al.
Publicado: (2001) -
Semi-allogeneic dendritic cells can induce antigen-specific T-cell activation, which is not enhanced by concurrent alloreactivity.
por: Wells, J, et al.
Publicado: (2007) -
Dendritic cell-based immunotherapy for myeloid leukemias
por: Christian Martijn Schürch, et al.
Publicado: (2013-12-01)